🔎 Trials Near Me

ホーム › 急性骨髄性白血病 › ウィスコンシン › Madison

Madison、WIにおける急性骨髄性白血病の臨床試験

Madisonとその周辺地域(約30マイル以内)の拠点で、急性骨髄性白血病に関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

被験者募集中第2相
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
18歳以上 · 全性別 · 2026/10/05更新 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

被験者募集中観察研究健康なボランティア歓迎
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

被験者募集中第2相
  • William S Middleton VA Medical Center, Madison
18歳以上 · 全性別 · 2026/09/22更新 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

被験者募集中第2相
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
18歳〜59歳 · 全性別 · 2026/09/22更新 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

被験者募集中第2相
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
18歳以上 · 全性別 · 2026/09/22更新 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

被験者募集中第3相
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
6 Months – 21 Years · 全性別 · 2026/09/17更新 · NCT04293562

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

被験者募集中第3相
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
1歳〜25歳 · 全性別 · 2026/09/04更新 · NCT07022678

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

被験者募集中第3相
  • University of Wisconsin, Madison
18歳以上 · 全性別 · 2026/08/20更新 · NCT07007312

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

被験者募集中観察研究
  • University of Wisconsin - Madison, Madison
全年齢 · 全性別 · 2026/07/06更新 · NCT01351545

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

被験者募集中第1相
  • University of Wisconsin Carbone Cancer Center, Madison
18歳以上 · 全性別 · 2026/05/14更新 · NCT06222580

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

被験者募集中第1相
  • University of Wisconsin Carbone Cancer Center, Madison
21歳以下 · 全性別 · 2026/04/22更新 · NCT05101551

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

被験者募集中第1相
  • University of Wisconsin Hospital and Clinics, Madison
18歳以上 · 全性別 · 2026/03/13更新 · NCT05735184

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

被験者募集中第1相
  • University of Wisconsin Carbone Cancer Center, Madison
7 Months – 21 Years · 全性別 · 2025/10/16更新 · NCT02508038

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

被験者募集中第1相
  • University of Wisconsin Clinical Science Center, Madison
18歳以上 · 全性別 · 2025/09/24更新 · NCT06501196

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

被験者募集中健康なボランティア歓迎
  • University of Wisconsin, Madison
18歳〜120歳 · 全性別 · 2025/07/25更新 · NCT05237258

他の都市における急性骨髄性白血病の試験

Madisonにおける他の研究

ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。